论文部分内容阅读
吉非罗齐降脂疗效观察附属医院心内科刘培晶，钱骏，任国庆，张树春吉非罗齐（Ｇｅｍｆｉｂｒｏｚｉｌ，又名Ｌｏｐｉｄ）是１９６８年研制成的新型血脂调节剂，最近十多年来国内外对其降脂作用、副反应及其机理进行了广泛的临床研究［１～３］。本文报告我院采用无锡市第...
Gemfibrozil (Lipid) is a new lipid-lowering regulator developed in 1968. In recent ten years, Gemfibrozil (also known as Lopid) In addition to its lipid-lowering effects, side effects and mechanism of a wide range of clinical studies [1 ~ 3]. This report reported Wuxi hospital using the first ...